3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
7
Rectal Neoplasms
3
Colorectal Neoplasms
3
Stomach Neoplasms
2
Neoplasm, Residual
2
Mesothelioma, Malignant
2
Colonic Neoplasms
2
Uterine Cervical Neoplasms
1
Solitary Fibrous Tumor, Pleural
1
Sarcopenia
1
Sarcoglycanopathies
1
Peritoneal Neoplasms
1
Pancreatic Neuroendocrine Tumors (pNET)
1
Pancreatic Neoplasms
1
Nasopharyngeal Carcinoma
1
NSCLC
1
Mesothelioma
1
Melanoma
1
Malnutrition
1
Lung Neoplasms
1
HER2 Negative Breast Cancer
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Frailty
1
Esophageal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Biliary Tract Neoplasms
1
Interventions
atezolizumab
3
Specimen Handling
2
spartalizumab
1
selinexor
1
sargramostim
1
pembrolizumab
1
pazopanib
1
fludarabine
1
cediranib
1
cabozantinib
1
atropine sulfate-diphenoxylate hydrochloride drug combination
1
anlotinib
1
Zoledronic Acid
1
Warfarin
1
Vitamin B 6
1
Thyroxine
1
Tablets
1
Sunitinib
1
Rosuvastatin Calcium
1
Radiotherapy
1
Radiation
1
Pyridoxine
1
Promethazine
1
Prochlorperazine
1
Petrolatum
1
Midazolam
1
Lorazepam
1
Loperamide
1
Immunoglobulin G
1
Ifosfamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Alveolar Soft Part
×
Chemotherapy, Adjuvant
×
1 year
×
Clear all
No trials found.